Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALVR |
---|---|---|
09:32 ET | 299 | 0.7319 |
09:34 ET | 553 | 0.7439 |
09:43 ET | 150 | 0.7344 |
09:52 ET | 100 | 0.7302 |
09:57 ET | 100 | 0.7303 |
10:15 ET | 100 | 0.7306 |
10:30 ET | 100 | 0.7539 |
10:33 ET | 100 | 0.7312 |
11:02 ET | 136 | 0.74265 |
11:06 ET | 1701 | 0.7406 |
11:09 ET | 2751 | 0.7398 |
11:11 ET | 229 | 0.748 |
11:13 ET | 100 | 0.748 |
11:15 ET | 427 | 0.7398 |
11:18 ET | 100 | 0.748 |
11:20 ET | 480 | 0.748 |
11:22 ET | 125 | 0.7423 |
11:26 ET | 224 | 0.7423 |
11:31 ET | 124 | 0.7455 |
11:36 ET | 123 | 0.74525 |
11:42 ET | 118 | 0.74525 |
11:45 ET | 2300 | 0.751 |
11:51 ET | 216 | 0.7455 |
11:56 ET | 427 | 0.751 |
12:02 ET | 115 | 0.7455 |
12:05 ET | 111 | 0.7455 |
12:12 ET | 111 | 0.7455 |
12:16 ET | 6164 | 0.749 |
12:18 ET | 7604 | 0.7499 |
12:20 ET | 100 | 0.7497 |
12:21 ET | 507 | 0.7497 |
12:23 ET | 200 | 0.7497 |
12:25 ET | 208 | 0.74485 |
12:27 ET | 300 | 0.7497 |
12:32 ET | 306 | 0.7497 |
12:34 ET | 500 | 0.7497 |
12:36 ET | 205 | 0.74485 |
12:38 ET | 200 | 0.7497 |
12:39 ET | 11900 | 0.74485 |
12:41 ET | 904 | 0.7475 |
12:43 ET | 1200 | 0.7474 |
12:45 ET | 2205 | 0.7473 |
12:48 ET | 100 | 0.74365 |
12:50 ET | 100 | 0.74365 |
12:52 ET | 303 | 0.74365 |
12:54 ET | 200 | 0.7472 |
12:56 ET | 202 | 0.7436 |
12:57 ET | 700 | 0.7472 |
01:01 ET | 224 | 0.740101 |
01:03 ET | 200 | 0.7471 |
01:06 ET | 110 | 0.74355 |
01:08 ET | 100 | 0.74745 |
01:10 ET | 1691 | 0.74745 |
01:12 ET | 405 | 0.7475 |
01:14 ET | 200 | 0.74745 |
01:15 ET | 104 | 0.74745 |
01:17 ET | 900 | 0.7474 |
01:19 ET | 1243 | 0.75 |
01:21 ET | 300 | 0.75 |
01:24 ET | 200 | 0.75 |
01:26 ET | 303 | 0.7487 |
01:28 ET | 100 | 0.7487 |
01:30 ET | 100 | 0.75 |
01:32 ET | 106 | 0.7487 |
01:33 ET | 100 | 0.7487 |
01:35 ET | 107 | 0.7487 |
01:37 ET | 600 | 0.7499 |
01:42 ET | 11500 | 0.75 |
01:44 ET | 11633 | 0.75 |
01:46 ET | 606 | 0.7487 |
01:48 ET | 200 | 0.74935 |
01:50 ET | 100 | 0.7499 |
01:51 ET | 8287 | 0.7469 |
01:55 ET | 143 | 0.7435 |
02:04 ET | 1440 | 0.7469 |
02:06 ET | 300 | 0.7444 |
02:08 ET | 14268 | 0.7445 |
02:09 ET | 291 | 0.7445 |
02:11 ET | 5513 | 0.7468 |
02:13 ET | 100 | 0.7462 |
02:15 ET | 400 | 0.7466 |
02:18 ET | 200 | 0.7466 |
02:20 ET | 200 | 0.7466 |
02:22 ET | 800 | 0.7466 |
02:24 ET | 200 | 0.7433 |
02:29 ET | 600 | 0.7466 |
02:31 ET | 1200 | 0.7466 |
02:33 ET | 559 | 0.7474 |
02:36 ET | 10200 | 0.748 |
02:38 ET | 100 | 0.75 |
02:42 ET | 400 | 0.748 |
02:44 ET | 2932 | 0.75 |
02:45 ET | 1404 | 0.75 |
02:47 ET | 500 | 0.75 |
02:49 ET | 200 | 0.75 |
02:51 ET | 200 | 0.75 |
02:54 ET | 100 | 0.75005 |
02:56 ET | 400 | 0.75 |
02:58 ET | 100 | 0.7502 |
03:00 ET | 300 | 0.75005 |
03:02 ET | 27268 | 0.753 |
03:03 ET | 1100 | 0.756 |
03:05 ET | 1372 | 0.75515 |
03:07 ET | 200 | 0.7513 |
03:09 ET | 1869 | 0.75 |
03:14 ET | 100 | 0.7513 |
03:16 ET | 100 | 0.7513 |
03:18 ET | 100 | 0.743 |
03:20 ET | 800 | 0.7469 |
03:21 ET | 100 | 0.7423 |
03:23 ET | 28097 | 0.7414 |
03:25 ET | 100 | 0.74385 |
03:30 ET | 100 | 0.74385 |
03:32 ET | 600 | 0.7439 |
03:34 ET | 300 | 0.7477 |
03:36 ET | 1300 | 0.7425 |
03:38 ET | 600 | 0.7425 |
03:39 ET | 1600 | 0.7449 |
03:41 ET | 2369 | 0.7449 |
03:43 ET | 564 | 0.7402 |
03:45 ET | 1600 | 0.7401 |
03:48 ET | 200 | 0.7401 |
03:50 ET | 1200 | 0.7425 |
03:52 ET | 200 | 0.7401 |
03:54 ET | 1100 | 0.7401 |
03:56 ET | 7494 | 0.7425 |
03:57 ET | 2523 | 0.7401 |
03:59 ET | 17004 | 0.7424 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Allovir Inc | 85.4M | -0.4x | --- |
PMV Pharmaceuticals Inc | 82.8M | -1.2x | --- |
Verastem Inc | 82.8M | -0.7x | --- |
DiaMedica Therapeutics Inc | 88.1M | -4.2x | --- |
IO Biotech Inc | 82.4M | -0.7x | --- |
Connect Biopharma Holdings Ltd | 82.1M | -1.4x | --- |
AlloVir, Inc. is an allogeneic T cell immunotherapy company with a focus on restoring natural immunity against life-threatening viral diseases in pediatric and adult patients with weakened immune systems. The company’s proprietary technology platforms leverage off-the-shelf, allogeneic, single- and multi-virus-specific T cells for patients with T cell deficiencies who are at risk from the life-threatening consequences of viral diseases. Its technology and manufacturing process enable the potential for the treatment and prevention of a spectrum of devastating viruses with each single allogeneic cell therapy. Its lead product candidate, posoleucel, is a multi-VST therapy that targets six viruses: adenovirus (BKV), cytomegalovirus (EBV), human herpesvirus 6 (HHV-6) and JC virus (JCV). Its proprietary VST manufacturing platform enables the rapid, robust and reproducible generation of single-virus and multi-virus specific cell therapeutic candidates for clinical use.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $85.4M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 115.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.77 |
EPS | $-1.65 |
Book Value | $1.28 |
P/E Ratio | -0.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.